David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.47% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRT
2426
DELISTED
HireRight Holdings Corporation
HRT
| $2.22M | ﹤0.01% |
155,652
+81,102
| +109% | +$1.09M |
|
2427
Insperity
NSP
$1.98B
| $2.22M | ﹤0.01% |
20,233
-1,639
| -7% | -$174K |
|
|
APLS
2428
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $2.22M | ﹤0.01% |
37,700
+8,200
| +28% | +$523K |
|
2429
PUT
Five Below
FIVE
$13.7B
| $2.21M | ﹤0.01% |
12,200
+2,200
| +22% | +$424K |
|
|
PEGR
2430
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $2.21M | ﹤0.01% |
200,000
| – | – |
|
2431
Evertec
EVTC
$1.76B
| $2.21M | ﹤0.01% |
55,275
+18,037
| +48% | +$711K |
|
|
CNSL
2432
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $2.19M | ﹤0.01% |
507,809
-340,150
| -40% | -$1.48M |
|
2433
ArcBest
ARCB
$3.1B
| $2.19M | ﹤0.01% |
+15,388
| New | +$2.02M |
|
2434
Etsy
ETSY
$7.63B
| $2.19M | ﹤0.01% |
31,875
+13,484
| +73% | +$968K |
|
2435
PUT
LKQ Corp
LKQ
$6.42B
| $2.19M | ﹤0.01% |
41,000
| – | – |
|
2436
DHI Group
DHX
$178M
| $2.19M | ﹤0.01% |
857,946
-185,118
| -18% | -$462K |
|
|
SMLR
2437
DELISTED
Semler Scientific
SMLR
| $2.19M | ﹤0.01% |
74,867
-50,720
| -40% | -$2.12M |
|
|
CFFS
2438
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $2.18M | ﹤0.01% |
200,000
-200,000
| -50% | -$2.18M |
|
2439
Voyager Therapeutics
VYGR
$213M
| $2.18M | ﹤0.01% |
233,989
-172,055
| -42% | -$1.45M |
|
2440
Gerdau
GGB
$9.2B
| $2.18M | ﹤0.01% |
+590,706
| New | +$2.14M |
|
|
CMBT
2441
CMB.TECH NV
CMBT
$5.3B
| $2.17M | ﹤0.01% |
130,682
-46,658
| -26% | -$813K |
|
2442
Curtiss-Wright
CW
$22.5B
| $2.17M | ﹤0.01% |
8,488
+60
| +0.7% | +$13.9K |
|
|
TCN
2443
DELISTED
Tricon Residential Inc.
TCN
| $2.17M | ﹤0.01% |
194,400
+184,400
| +1,844% | +$1.97M |
|
2444
Green Brick Partners
GRBK
$3.12B
| $2.17M | ﹤0.01% |
35,989
-153,088
| -81% | -$8.21M |
|
2445
Perimeter Solutions
PRM
$5.28B
| $2.16M | ﹤0.01% |
291,366
-57,439
| -16% | -$309K |
|
2446
CALL
CME Group
CME
$101B
| $2.15M | ﹤0.01% |
10,000
-10,000
| -50% | -$2.1M |
|
2447
Arcutis Biotherapeutics
ARQT
$3.13B
| $2.15M | ﹤0.01% |
+216,866
| New | +$1.62M |
|
2448
Pultegroup
PHM
$24.2B
| $2.15M | ﹤0.01% |
17,808
-35,882
| -67% | -$3.85M |
|
2449
Stevanato
STVN
$6.09B
| $2.14M | ﹤0.01% |
66,735
-45,717
| -41% | -$1.39M |
|
2450
IonQ
IONQ
$17.2B
| $2.14M | ﹤0.01% |
214,428
-1,066,376
| -83% | -$11.4M |
|
Similar funds
David Shaw's Q1 2024 Portfolio in Review
As of Q1 2024, David Shaw held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- David Shaw's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- David Shaw added most to Apple in Q1 2024, an estimated $820M increase.
- David Shaw's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- David Shaw fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- David Shaw's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- David Shaw opened 655 new positions and closed 634 in Q1 2024.
- David Shaw's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.